Celularity Inc. Form 8-K Summary
Business context and reporting period
Celularity Inc. filed this Current Report on August 16, 2021, under Item 2.02 to announce financial results as of and for the quarter ended June 30, 2021. The filing identifies Celularity as a Delaware corporation headquartered in Florham Park, New Jersey, with Class A common stock and warrants traded on Nasdaq under the symbols CELU and CELUW.
Financial results and liquidity
The filing states that the company issued a press release announcing its quarterly financial results, included as Exhibit 99.1. The provided filing text does not include the underlying press release or clear values for revenue, profit or loss, cash flow, margins, debt, cash, liquidity, or other financial metrics.
Material changes versus the prior comparable period
The provided text does not describe specific changes versus the prior-year or prior-quarter comparable period.
Guidance, outlook, risks, and unusual items
No guidance, outlook, management commentary, risk discussion, contingencies, or unusual items are included in the provided text. Investors should review Exhibit 99.1 for the company’s complete financial results and related commentary.
Key facts to verify
- Obtain and review Exhibit 99.1, the August 16, 2021 earnings press release.
- Verify reported revenue, net loss, adjusted metrics, cash position, operating cash flow, debt, and liquidity as of June 30, 2021.
- Compare the quarter’s results with the prior comparable period and assess any disclosed changes in operating performance.
- Review any guidance, financing needs, business risks, and contingencies disclosed in the press release.
- Note that Item 2.02 information, including Exhibit 99.1, is not deemed filed for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference.